IDI Logo Home  |   FAQ  |   Glossary of Terms   |  Search    
Enter Keyword
No Flash Image
Horizontal Line
DISORDERS  :   PUBLICATIONS  :   IRON LIBRARY  :   FOR PHYSICIANS  :   IRON STORE  :   CONTACT US  :   ABOUT IDI  
Horizontal Line
Conference
  What Is Iron USA
  A Special Note
  Message Board

Conference Info
   Browse
   Register Now!
   
     Iron USA 2006 Highlights!



Prad Phatak, M.D.-is Vice Chair of Iron Disorders Institute (IDI) Scientific Advisory Board and Conference Chair. He will present an introduction to hemochromatosis/iron overload including tests to confirm diagnosis and treatment for hemochromatosis.

Susan Leitman, M.D.-is principal investigator for the NIH Hemochromatosis Protocol, which is underway at the Warren G. Magnuson Clinical Center, NIH campus. She will present on Double Red Cell Apheresis (DRCA), a treatment option for patients with classic hemochromatosis.

Kris Kowdley, M.D.-is a member of the IDI Scientific Advisory Board and responsible for the University of Washington, Seattle iron overload clinic. He will discuss cutting edge technology, a non-invasive way to qualify and quantify liver iron: Ferriscan

Mark Wurster, M.D. -is a member of the IDI Scientific Advisory Board and responsible for the hemochromatosis program at Ohio State University Health Center. Dr. Wurster will discuss iron avidity, a common phenomenon for hemochromatosis patients.

Heidi Blanck, Ph.D.-is Hemochromatosis Team Leader, US Centers for Disease Control and Prevention, Atlanta. She will discuss the CDC healthcare provider online hemochromatosis training program.

John Beard, Ph.D.-is a member of the IDI Scientific Advisory Board. He will discuss dietary recommendations for different phases of treatment - induction, treatment, maintenance and for conditions of iron avidity.

Mary Frances Picciano, Ph.D.-Appropriateness of supplementation in hemochromatosis patients

Gene Weinberg, Ph.D,-is a member of the IDI Scientific Advisory Board and Publications Chair. He will discuss the effects of iron loading on susceptibility and treatment to specific infectious diseases among hemochromatotics: H. pylori vibrio, yersinia, AID's hepatitis, tuberculosis and arteriosclerosis.

Aran Gordon-is Chairman of IDI's Board of Trustees and a Vice President with T. Rowe Price. Aran will discuss his participation in the Marathon des Sables, a 150-mile footrace in the Sahara Desert. In the 2005 event, Aran finished in the top half of participants who completed the event. He plans to run again in 2006 and will provide highlights of his experience for conference attendees.



EXTRA HIGHLIGHTS INFORMATION
Download The Highlights Document

Read More About Chairman, Aran Gordon




**The agenda is subject to change, but we assure you a very interesting and worthwhile experience!**





Sponsors
                               Verify Here

Last modified: 11/3/2006
POLICY : DISCLAIMERS : CONTACT US : LINKS

Iron Disorders Institute is a 501(c)3 voluntary health public interest
organization headquarters in Greenville, South Carolina
Corporate Headquarters: 2722 Wade Hampton Blvd, Suite A
Greenville, SC 29615 864-292-1175 FAX 864-292-1878